Maternal Mortality and COVID-19 Pandemic: Looking Beyond SARS CoV-2 Infection.
Ratna Biswas1, Manju Puri2, Abha Singh3
1Director Professor, Department of Obstetrics and Gynecology, Lady Hardinge Medical College & Sucheta Kriplani Hospital (LHMC & SSKH), Shahid Bhagat Singh Marg, New Delhi, 110001 India.
Journal of Obstetrics and Gynaecology of India
|March 4, 2024
Summary
The COVID-19 pandemic significantly increased maternal mortality ratio (MMR) due to fewer hospital births. Lessons learned are crucial for future pandemic preparedness and maternal health planning.
Area of Science:
- Obstetrics and Gynecology
- Public Health
- Infectious Diseases
Background:
- The COVID-19 pandemic presented unprecedented challenges to healthcare systems globally.
- Maternal mortality remains a critical indicator of healthcare quality and accessibility.
Purpose of the Study:
- To assess the impact of the COVID-19 pandemic on maternal mortality ratio (MMR).
- To identify etiological and modifiable factors contributing to maternal deaths during the pandemic.
- To evaluate key interventions implemented for maternal care during the study period.
Main Methods:
- A retrospective exploratory study design was employed.
- Maternal mortality data from April to November 2020 (study group) were compared with data from April to November 2019 (control group).
- Demographic characteristics, causes of death, care-seeking delays, and interventions were analyzed.
Main Results:
- The maternal mortality ratio (MMR) was significantly higher in the study group (792 vs. 296, p=0.0).
- Hemorrhage (20%) and COVID-19-related deaths (15%) were leading causes in the study group. A higher proportion of deaths occurred within 24 hours of admission (45% vs. 20%, p=0.04).
- Increased maternal age and illiteracy were more prevalent in the study group. Supplemental oxygen use was significantly higher in the study group (p=0.02).
Conclusions:
- The COVID-19 pandemic led to a substantial increase in maternal mortality, linked to a decline in hospital delivery rates.
- Factors such as hemorrhage, COVID-19 infection, and delays in care contributed to increased mortality.
- Documenting lessons learned is essential for improving future pandemic preparedness and maternal health strategies.
Related Concept Videos
Disorders of the Female Reproductive System
358
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
358
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Meiosis vs. Mitosis
55.6K
Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
55.6K


